
Here are the latest updates on the approval and upcoming sales of Presvu Eye Drops:
- Government Approval: The Drug Controller General of India (DCGI) has approved Presvu Eye Drops, developed by Entod Pharmaceuticals.
- Vision Improvement: These eye drops can improve vision within 15 minutes of application.
- Sales Launch: Presvu Eye Drops will be available for sale starting next month.
- Target Condition: The eye drops are designed to treat presbyopia, a common age-related vision problem.
- Market Impact: This approval marks a significant advancement in eye care innovation in India.
- Usage Benefits: Presvu Eye Drops aim to reduce the reliance on reading glasses for individuals with presbyopia.
- Product Availability: The eye drops will be launched in the domestic market in the first week of October.
- Global Reach: Entod Pharmaceuticals plans to expand the product to emerging markets such as Africa and Southeast Asia.
- Cost: The eye drops will be available at a cost of Rs 350 per bottle.
- Expert Opinion: Dr. Aditya Sethi highlighted that Presvu Eye Drops can significantly improve near vision, enhancing the quality of life for many.
-
Maximize Gains with Groww Pledging: Trade Smarter in India’s Stock Market
This guide reveals how Groww’s pledge feature works, its jaw-dropping benefits, and hidden risks. Compare Groww vs Zerodha
-
International Stock Market Analysis on Monday, August 4, 2025
What was the international stock market like on August 4, 2025? U.S.-China trade tensions escalate with 18% tariffs,
-
Indian Stock Market Outlook for Monday, 04-08-2025
Will the Indian stock market rebound or plummet on 04 August 2025? As Sensex and Nifty50 hover near
-
Bank of Baroda’s Jeevan Suraksha Savings Account: No Medical Exam, ₹5 Lakh Cover!
Bank of Baroda Jeevan Suraksha Savings Account – blending savings with up to ₹5 lakh life insurance—no medical